Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Protalix Biotherapeutics Inc. revenue for the quarter ending March 31, 2026 was 33.8 M, a 233.73% increase year-over-year.
- Protalix Biotherapeutics Inc. revenue for the twelve months ending March 31, 2026 was 77.4 M, a 69.95% increase year-over-year.
- Protalix Biotherapeutics Inc. annual revenue for 2025 was 52.7 M, a 1.23% decrease from 2024.
- Protalix Biotherapeutics Inc. annual revenue for 2024 was 53.4 M, a 18.47% decrease from 2023.
- Protalix Biotherapeutics Inc. annual revenue for 2023 was 65.5 M, a 37.48% increase from 2022.
- Protalix Biotherapeutics Inc. annual revenue for 2022 was 47.6 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Protalix Biotherapeutics Inc. Market Cap — FAQ
Protalix Biotherapeutics Inc. (PLX) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's market cap history?
The chart and table above show Protalix Biotherapeutics Inc.'s market cap by year and by quarter, including the growth rate.